Klaviyo's Strong Q1 2026: Growth and Margins In Line, But No Relief from Key Risks

What happened

Klaviyo reported Q1 2026 revenue growth of 28% YoY, a record non-GAAP operating margin, and raised its full-year outlook, indicating continued execution against its AI-first B2C CRM strategy. The results align with the base case scenario in our prior analysis, which projected mid-20s growth and expanding margins, but do not address the two central risks: Shopify concentration (77.7% of ARR) and incremental gross-margin pressure from rising SMS and AI infrastructure costs. Management’s narrative remains qualitative regarding AI agent attach rates and ARR contribution, with no new quantitative disclosures to validate the AI-driven expansion thesis. The raised guidance suggests confidence in sustaining growth, yet the lack of detail on net revenue retention (NRR) trends leaves a critical uncertainty unresolved. Overall, the quarter confirms the operational trajectory but does not materially alter the risk-reward calculus at current valuation.

Implication

Klaviyo delivered a solid Q1 with 28% revenue growth and record margins, in line with the base case of mid-20s growth and margin expansion. However, the absence of updated NRR and gross-margin details means the two central risks—Shopify concentration and AI/SMS cost pressure—remain unaddressed. The raised full-year outlook provides upside to near-term estimates but does not change the medium-term thesis. Investors should monitor upcoming filings for NRR and Shopify revenue-share disclosures. At ~$31-32 (post-earnings move), the stock trades near our base-case target of $36, limiting upside without catalysts to resolve risk factors. We recommend maintaining position size and waiting for a better entry or risk clarification before adding.

Thesis delta

The Q1 2026 results confirm our base-case thesis of sustained mid-20s growth and margin expansion, with no negative surprises. However, the lack of additional data on NRR and gross margin means the key risks we flagged remain active, and the stock price has moved closer to our $36 target, reducing near-term upside. No material shift in thesis is warranted; the stock's risk-reward remains balanced but less attractive after the post-earnings price increase.